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ABSTRACT The assembly of single-chain Fv (scFv) antibody fragments, consisting of an interconnected variable heavy
chain (VH) and variable light chain (VL), is a cooperative process that requires coupled folding and domain association. We
report here an initial investigation of VH/VL domain-domain assembly with a site-directed mutagenesis study that probes a
highly conserved VH/VL hydrogen bonding interaction. Gln
168 of the S5 scFv (Kabat VH 39) is absolutely conserved in 95%
of all VH, and Gln
44 (Kabat VL 38) is found in 94% of all  VL (Glx in 95% of all  VL). These side chains form two hydrogen
bonds in head-to-tail alignment across the VH/VL interface. Double mutant cycles at Gln
168 and Gln44 were constructed to first
investigate their contributions to thermodynamic folding stability, second to investigate whether stability can be improved,
and third to determine whether refolding efficiencies are affected by mutations at these positions. The results demonstrate
that the Gln168-Gln44 interaction is not a key determinant of S5 scFv folding stability, as sequential modification to alanine has
no significant effect on the free energy of folding. Several mutations that alter the glutamines to methionine or charged amino
acids significantly increase the thermodynamic stability by increasing the mg associated with the unfolding isotherm. These
effects are hypothesized to arise largely from an increase in the VH/VL association free energy that leads to tighter coupling
between domain-domain association and folding. All of the mutants also display a reduced antigen binding affinity. Single and
double methionine mutants also displayed significant increases in refolding efficiency of 2.4- to 3-fold over the native scFv,
whereas the double alanine/methionine mutants displayed moderate 1.9- to 2.4-fold enhancement. The results suggest that
reengineering the VH/VL interface could be useful in improving the stability of single-chain antibodies, as Ala/Met mutations
at these conserved positions increase the free energy of folding by 46% while minimally perturbing binding affinity. They also
could be useful in improving scFv recovery from inclusion bodies as the mutations increase the refolding efficiency by more
than twofold.
INTRODUCTION
The protein folding problem has largely been approached
from the perspective of small, discrete folding units or
subunits. The next level of organization, domain-domain
assembly, remains an important challenge for which much
less detailed kinetic and thermodynamic characterization
exists. It is interesting to note, for example, that many
dimeric proteins are characterized by an apparent two-state
folding equilibrium (Neet and Timm, 1994; Sauer et al.,
1996). This implies a highly cooperative assembly process,
but the molecular mechanisms by which individual domain
folding is coupled to domain-domain association are poorly
understood. The IgG antibody family is a good example in
which global protein folding is coupled to domain associa-
tion. The FAB fragment requires the folding of the VH and
CH1 of the heavy chain and the VL and CL of the light chain,
along with association across the VH/VL and CH1/CL inter-
faces. Equilibrium and kinetic studies of FAB and subunits
of FAB have demonstrated the coupling of folding to do-
main association and the coupling of VH/VL interactions
and CH1/CL interactions (Rowe and Tanford, 1973; Rowe,
1976; Hochman et al., 1976; Klein et al., 1979; Horne et al.,
1982; Tsunenaga et al., 1987). Recent kinetic studies by
Lilie et al. (1995) have supported a FAB folding scheme
that is initiated by the fast folding of individual domains
coupled to domain-domain association, with subsequent
formation of folding intermediates differing in prolyl
isomerization and potentially in specific interface contacts.
Single-chain Fv antibodies (scFv) represent another in-
teresting model system for studying domain-domain assem-
bly. scFv antibodies are genetically engineered antibody
fragments consisting of the variable heavy and variable light
domains of intact monoclonal antibodies, connected
through a synthetic linker of 15 amino acids (Bird et al.,
1988). The study of domain-domain assembly in the scFv
model system reduces the complexity of the FAB system to
two interconnected folding units and one association inter-
face. Because the folding and the association of the variable
domains at the VH/VL interface are structurally coupled to
the CH1/CL interface in nature, it is unclear whether the
isolated scFv VH/VL domains and interface are optimized in
terms of folding stability and mechanism. The study of
domain-domain assembly in the scFv model system could
thus potentially provide designs that improve the scFv for
technological applications. The scFv are widely considered
to be relatively unstable, and in the few reported cases in
which thermodynamic stability has been measured, the fold-
ing free energy is indeed small. Pantoliano et al. (1991)
have studied the equilibrium unfolding of a fluorescein-
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binding scFv, and reported the thermodynamic effects of
derivatives differing in the length of the interconnecting
linker. They observed a two-state unfolding transition with
a folding free energy of 4.33 kcal/mol for the anti-fluores-
cein scFv. Voss and co-workers have similarly observed a
two-state unfolding transition with an anti-ssDNA scFv, and
obtained a folding free energy of just 1.44 kcal/mol (Gul-
liver et al., 1995). Interestingly, the grafting of heavy-chain
CDR loops from the fluorescein-binding scFv to the anti-
ssDNA scFv led to a substantial increase in the folding
stability of the latter scFv. A mechanistic study of scFv
fragment folding by Freund et al. (1996) has provided the
first detailed kinetic characterization and provides evidence
for the formation of a folding intermediate varying in prolyl
isomerization. Other studies have shown that engineered
disulfide linkages and chemical cross-linking across the
VH-VL interface can significantly increase the thermal sta-
bility of Fv antibodies and provide important routes for
improved refolding properties (Glockshuber et al., 1990;
Reiter et al., 1994).
We report here an initial site-directed mutagenesis and
thermodynamic and refolding efficiency study of the scFv
VH/VL interface. Double mutant cycles have been con-
structed at a highly conserved hydrogen bonding pair,
formed between glutamine 44 (Kabat VL 38) and glutamine
168 (Kabat VH 39) (Kabat et al., 1991; Chothia et al., 1985).
The glutamine of the heavy chain is conserved in 95% of all
heavy chain classes, whereas the glutamine of the light
chain is 95% conserved in all  light chains and found as
Glx in 95% of  light chains (Kabat et al., 1991). The two
amide groups are aligned head to tail with respect to the
amino and carbonyl functionalities, forming two hydrogen
bonds that close the hydrophobic zipper of the highly con-
served VH/VL interface.
MATERIALS AND METHODS
Materials
All oligonucleotides for mutagenesis work were purchased from Integrated
DNA Technologies (Coralville, IA). Most chemicals were purchased from
Sigma (St. Louis, MO) or ICN (Costa Mesa, CA). All restriction endo-
nucleases were purchased from New England Biolabs (Beverly, MA).
Molecular modeling of S5 scFv structure
A search of the Swiss-Protein database resulted in a high sequence align-
ment fit to the McPC603 antibody (Satow et al., 1986). The S5 scFv had
67% exact match VH alignment (93% conservative match) and 69% exact
match VL alignment (92% conservative match) to McPc603. This close
sequence homology allowed the construction of a three-dimensional model
of S5 using the software package Homology (Biosym, San Diego, CA).
Briefly, the two sequences were aligned, and coordinates from McPc603
were transferred to S5 scFv, while coordinates for the linker were assigned
by random search for the lowest energy conformation. The structure was
then relaxed with the Discover program (InsightII, Biosym) by selective
minimization of all atoms of the CDR loops and the side chains in the
framework residues that were replaced. The backbone atoms of the frame-
work were not minimized because of the close identity and conservation
between McPC603 and S5 (Chothia and Lesk, 1986).
Construction of interface mutant
The cloning of the VL and VH genes and the construction of the anti-CD44
S5 scFv has been described previously (Tan et al., 1995). The complete
construct consists of the VL domain at the N-terminus linked to the VH
domain at the C-terminus via a 15 amino acid linker [Gly4Ser]3. For the
current studies, we first constructed the S5 scFv with an N-terminal
histidine tag (His-tag) using the pET16b (Novagen, Madison, WI) expres-
sion plasmid vector. Subsequent binding studies, however, demonstrated
that the N-terminal His-tag interfered with the antigen binding affinity. We
then used polymerase chain reaction (PCR) mutagenesis techniques to
introduce a C-terminal His-tag, and this scFv displayed an enzyme-linked
immunosorbent assay (ELISA) EC50 identical to that of the native scFv.
All of the site-directed mutants have the same His6 C-terminal extension,
which allowed the production of highly pure scFv from E. coli. This gene
was ligated into the pT7 Blue vector (Novagen) and used as a template for
the site-directed mutagenesis manipulations.
Glutamine 44 was substituted with different amino acid residues by
cassette mutagenesis. Sense (5-CTG RH (R A, G; H A, C,T) G AAG
CCA GGC CAG TCT CC-3) and antisense (5-CTT TGG AGA CTG
GCC TGG CTT CDY (D  G, A, T; Y  C, T) CAG GTA C-3)
degenerate oligonucleotides were annealed and inserted into the scFv
wild-type gene utilizing KpnI and BsmAI sites. The degenerate cassette
produces changes to alanine, glutamic acid, lysine, methionine, threonine,
and valine at position 44. The ligated vector was transformed into Nov-
ablue cells (Novagen), and the putative mutants were sequenced using dye
terminator chemistry with fluorescence detection of the sequencing prod-
ucts (Applied Biosystem, Foster City, CA). Clones of interest were se-
lected, and their inserts were ligated into the pET21a vector (Novagen) and
subsequently transformed into BL21 (DE) for expression.
Because of lack of convenient restriction sites, glutamine 168 was
substituted by PCR mutagenesis. A degenerate mutagenic sense primer
(5-CCA TGT CTT GGG TTC GCR HGA CTC CAG AAA AGA G-3)
was used in a first PCR reaction, together with a second antisense primer
(5-CCC GTC AAG CTT AGT GGT GAT GAT GGT GAT GTG AGG
AGA CGG TTA CCG TGG TAC CTG C-3) that coded for a stretch of six
histidine residues and a HindIII site at the 3 end. The extension of the
primers was performed with Vent Polymerase (New England Biolabs). The
primary PCR product was subsequently isolated and used in a second PCR
step, together with a 5 sense primer (5-GGG AAT TCC ATA TGG AAG
TGA AAC TGG TGG AGT CT-3) carrying an NdeI site that sets the ATG
start codon. In both steps, the wild-type scFv insert in pT7Blue was used
as the template. The secondary PCR product was isolated and cut with NdeI
and HindIII restriction enzymes, phenol/chloroform extracted, and ligated
into NdeI and HindIII cut pUC18 vector. For screening purposes, an EarI
site near the mutated residue was removed in the mutagenic primer so that
clones that do not have that EarI site were likely to contain the desired
mutagenic sequence alteration. Screened clones were selected and their
DNA sequenced. Clones with the desired mutation were selected and the
NdeI-HindIII insert ligated into pET21a and subsequently transformed into
BL21 (DE).
Double mutants were constructed by cassette mutagenesis utilizing the
two restriction sites, BsgI and SacI. The BsgI site is located between
positions 44 and 168, whereas the SacI site is at the 3 end of the gene.
After ligation, the gene carrying double mutation was transformed into
Novablue cells, screened by restriction mapping, and sequenced to select
for clones of interest. ScFv insert from desired clones was ligated into
pET21a and subsequently transformed into BL(DE). In all cases, the
mutated genes in the pET21a vector were sequenced to confirm the
presence of the desired mutation before expression.
Expression of scFv mutants
The BL21(DE) cells containing the mutated scFv insert in the pET21a
plasmid were grown overnight in 30 ml of Luria-Bertani (LB) medium
supplemented with 100 g/ml of ampicillin at 37°C with shaking. Cells
were washed two times with 2 YT media the following day and used to
1474 Biophysical Journal Volume 75 September 1998
inoculate 6 liters of 2 YT media. When the OD600 reached1.0, 0.2 mM
isopropyl-b-D-thiogalactopyranoside (IPTG) was added to induce scFv
expression. Cells were cultured for an additional 3 h and collected by
spinning at 4500  g for 10 min. The cell pellets were stored at 70°C
before inclusion body isolation.
In each liter of induced culture, the cell pellet was resuspended in 30 ml
of 50 mM Tris-HCl (pH 7.4), 8% sucrose, 3% Triton X-100, 300 mM
NaCl, and 1 mM phenylmethylsulfonyl fluoride (PMSF). The cell suspen-
sion was sonicated, and the insoluble fractions consisting of inclusion
bodies were centrifuged at 16,000  g for 20 min. The insoluble fraction
was washed three additional times. The inclusion bodies were sonicated
each time to form a homogeneous suspension and centrifuged at 16,000 
g for 20 min. The inclusion bodies were then solubilized in 6 M guanidine-
HCl, 100 mM NaH2PO4, and 10 mM Tris-HCl (pH 8.0) (binding buffer).
Purification of scFv mutants
Ni-NTA resin was purchased from Qiagen (Chatsworth, CA) and used to
pack a low-pressure 30-ml Econo-column (Biorad, Hercules, CA). The
solubilized protein solution was passed over the column that had been
preequilibrated with the binding buffer (see above). Fifteen column vol-
umes of binding buffer were passed over the column to remove unbound
protein, followed by 15 column volumes of washing buffer (6 M guani-
dine-HCl, 100 mM NaH2PO4, 0.5 M NaCl, 20 mM imidazole, 10 mM
Tris-HCl, pH 6.3) to remove proteins that nonspecifically bound to the
column. The bound protein was eluted using 6 M guanidine-HCl, 100 mM
NaH2PO4, 0.5 M NaCl, 250 mM imidazole, and 10 mM Tris-HCl (pH 6.3).
The eluted protein was precipitated by adding (NH4)2SO4; washed two
times with 50 mM Tris, 500 mM NaCl, and 2 mM mercaptoethanol; and
resolubilized in 6 M guanidine-HCl to a final concentration of 5–10
mg/ml, in preparation for refolding.
Refolding of scFv mutants
The solubilized protein was diluted 100-fold into a refolding buffer
consisting of 50 mM 3-[cyclohexylamino]-1-propanesulfonic acid (CAPS)
(pH 10.5), 0.35 M L-arginine, 0.1 mM PMSF, 2 mM EDTA, 1.25 mM
cysteine, and 0.5 mM cystine that had been chilled to 4°C. The mixture was
stirred for 1–2 h and left overnight at 4°C. On the following day, the
protein solution was extensively dialyzed against 50 mM Tris-HCl (pH 7.5)
and 150 mM NaCl that had been chilled to 4°C. The protein solution was
then centrifuged to remove any insoluble materials and concentrated using
an ultrafiltration cell (Amicon, Beverly, MA) to a volume of 3–10 ml. The
refolded protein was then analyzed by sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE) to check its purity, which was
90–99%. Concentrations of scFv were determined by its absorbance at 280
nm, using an extinction coefficient of 53,403 M1 cm1 and a molecular
weight of 27,427, which was calculated from the amino acid sequence of
wild-type scFv.
Chemical denaturation studies
A 7.2 M ultrapure guanidine-HCl solution in 50 mM Tris (pH 7.5) and 150
mM NaCl was prepared from 8 M guanidine-HCl solution (Fluka,
Ronkonkoma, NY). The unfolding transition of each mutant was deter-
mined by monitoring changes in the intrinsic fluorescence maximum on a
Hitachi spectrophotofluorometer F4500. A small volume (25 l) of the 7.2
M guanidine-HCl solution was first added to a 40 g/ml sample of each
protein in 50 mM Tris (pH 7.5) and 150 mM NaCl. At each further
addition, the sample was mixed and allowed to come to equilibrium. The
optical chamber was thermostatted at 22°C in all of the measurements,
which were performed in a 1 cm  1 cm quartz fluorescence cuvette. The
excitation wavelength was 290 nm, and the sample was scanned from 300
nm to 450 nm for each denaturant concentration. The fluorescence maxi-
mum was determined with a first-order derivative technique. There was a
14-nm red shift in fluorescence emission maximum upon denaturation of
the scFv, and we estimate the accuracy of the determination of maximum
wavelength of fluorescence emission to be 0.1–0.2 nm, based on analysis
of standards and on the reproducibility of the data.
Determination of Gn-u and mG from the
unfolding transitions
The Igor Pro (Lake Oswago, OR) software program was used to fit the
unfolding transition, using a two-state protein unfolding model. The fitting
equation is given below, which has been described by Santoro and Bolen
(1988):
Yobs
yuo muD	
exp Gnu mgD	/RT	
 yno mnD	
expGnu mgD	/RT	 1	
The six fitting parameters are yno (minima), mn (pretransitional slope), yuo
(maxima), mu (posttransitional slope), mg, and Gn-u of unfolding and Yobs
or max is the measured fluorescence maximum. Gn-u is the Gibbs free
energy of unfolding. The raw data (max) for each unfolding transition was
fit using the above equation. Each of the individual unfolding transitions
for the mutant data sets was independently analyzed. The data sets for each
mutant included a minimum of five individual unfolding experiments from
at least two independent protein preparations. The average and standard
deviation of Gn-u and mg were then determined across each data set. The
data was also fit to the three-state model, N 3 I 3 U. Assuming that the
quantum yield of the three species are similar (which is true for N and U),
the emission max should be directly related to the fraction of each species
present according to the following equation (Barrick and Baldwin, 1993):
max,obs max,nFn max,iFi max,uFu
Fn
1
1 K(ni) K(ni)K(iu)
Fi
K(ni)
1 K(ni) K(ni)K(iu)
Fu 1 Fn Fi
This equation can be further manipulated to give
max,obs

max,n max,iKn i max,uKn iKi u
1 Kn i Kn iKi u
where
K(ni) expG(ni) mgD/RT
K(iu) exp G(iu) mgD/RT
This nonlinear fitting equation involves seven fitting parameters, and the
pre- and posttransitional baselines are assumed to be flat.
Equilibrium fluorescence data for selected mutants displaying signifi-
cant mg and Gn-u were also analyzed according to a two-state model
using the numerically based program Bioeqs (Royer et al., 1990). Briefly,
this solver uses a constraint optimization routine employing Lagrange
mutlipliers to solve the free energy equation in terms of concentration of
the chemical denaturant employed (Royer, 1993). The free energy equation
used is Gobs  Gn-u  m[Gdn-HCl]. The pre- and posttransitional
regions of the folding isotherm are assumed to be flat. The raw data (max
versus denaturant concentration) were fitted to a two-state model using
BIOEQS. Values for mg, Gn-u, yn (minima), and yu (maxima) were
generated from the BIOEQS fitting. The program also generated the
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dependence of the 2 minimum as a function of Gn-u and mg. The 2 for
the 67% confidence limit was determined using an extension program of
the BIOEQS, allowing determination of the 67% confidence limit interval
for Gn-u and mg.
Determination of binding isotherm by competitive
ELISA assay
Canine thyroid adenocarcinoma cells (CTACs) that display the CD44
antigen were plated onto 96 flat-bottom well plates and allowed to grow to
confluency. The plates were washed two times with phosphate-buffered
saline (PBS) plus 0.05% Tween 20. Cells in the plates were fixed using
0.15% glutaraldehyde for 30 min. The wells were washed three times with
0.05% Tween 20 in PBS, and the remaining binding sites in the wells were
blocked by incubation with 100 l of 5% nonfat milk in PBS for 30 min.
Fifty microliters of scFv of varying concentrations (4 M to 6 102 nM)
in PBS containing 2% bovine serum albumin was added to each well in
duplicate, followed by an incubation of 30 min. A fixed amount of
biotinylated parental antibody (S5) (50 l of 3 nM protein) was added to
each well and incubated for another 30 min. The wells were washed three
times with Tween 20/PBS buffer. One hundred microliters of streptavidin-
horseradish peroxidase (HRP) conjugate (Tagoimmunological, Camarillo,
CA) was added to each well. After 30 min of incubation, the wells were
washed three times as above, and 2,2-azino-bis-3-ethylbenzthiazoline
sulfonic acid (ABTS) substrate solution (Pierce, Rockford, IL) was added
for color development. The optical density (OD) at 405 nm was measured
after 15 min with a microtiter plate reader (Molecular Devices). The
reading was blanked against wells in which no biotinylated S5 was added.
The data were processed with the Igor software to determine the equivalent
bulk concentration at 50% blocking of biotinylated S5 binding to the cells
(EC50), using a published four-parameter nonlinear fitting algorithm (Jin et
al., 1992): y  a  (d  a)/[1  exp (b(c  x))], where a, b, c, and d are
the adjustable fitting parameters, x is the bulk antibody concentration
(M), and y is the percentage block of biotinylated S5 binding. The EC50
in M is given by the value of the parameter c for the best fit of the fitting
function for the blocking isotherm.
Quantitation of refolding yield
Proteins used for these studies were purified using the Nickel immobilized
column as described in the above section. The guanidine-HCl-solubilized
proteins were analyzed by SDS-PAGE and found to be homogeneous. Fifty
micrograms of guanidine-HCl-solubilized protein was slowly dripped into
1 ml of refolding buffer consisting of 50 mM CAPS, 0.4 M L-arginine (pH
10.5), 1.25 mM cysteine, plus 0.5 mM cystine, and stirred overnight. The
amount of solubilized protein was quantitated by measuring the OD280, and
subsequently dialyzed using a dialysis cassette (Pierce) against 50 mM
Tris, 150 mM NaCl (pH 7.4) for 8 h. Protein samples were subsequently
centrifuged at 10,000  g for 5 min. The concentration of protein at the
endpoint of refolding was calculated by taking the OD280 reading. The
amount of protein was measured with a second independent method using
the micro bicinchoninic acid (BCA) protein assay (Pierce). At the endpoint
of refolding, 0.5 ml of BCA Protein assay reagent was added to 0.5 ml of
each sample and incubated at 60°C for 1 h. The OD at 562 nm was then
measured for each sample, and the amount of protein present was estimated
from a standard curve generated using bovine serum albumin.
Light scattering experiments
Fifty milligrams of guanidine-HCl-solubilized protein was added to 1 ml of
50 mM Tris, 150 mM NaCl, 1.25 mM cysteine, 0.5 mM cystine (pH 7.6).
After rapid mixing, the light scattering of the sample was recorded over a
5-min (300-s) period at 22°C on a Hitachi F4500 fluorescence spectropho-
tometer with excitation and emission wavelength set at 500 nm.
RESULTS
Molecular modeling of the S5 scFv
antibody structure
Our model single-chain antibody is the previously described
S5 scFv (Tan et al., 1995), whose monoclonal parent stim-
ulates a biochemical signaling cascade through the CD44
receptor that results in a remarkable increase in marrow
graft acceptance between MHC mismatched donor/acceptor
pairs (Sandmaier et al., 1990). The S5 scFv displays a close
sequence homology to the crystallographically defined
McPc603 antibody (Satow et al., 1986), with 67% exact
match VH alignment (93% conservative match) and 69%
exact match VL alignment (92% conservative match). Ho-
mology model building techniques were thus used to derive
a three-dimensional model for S5. Fig. 1 A shows the
overall fold of the scFv and the relationship of the Gln44-
Gln168 interaction to the complementarity determining loops
(CDR) and disulfide bonds. Fig. 1 B shows their relation-
FIGURE 1 Homology three-dimensional model of the S5 scFv (MOL-
SCRIPT; Kraulis, 1991). (A) The S5 single-chain antibody with the VL
domain on the left and VH domain on the right interconnected via a peptide
linker (indicated by the black coil). The Gln44-Gln168 pair is shown as ball
and stick, the CDR loops are represented by gray shading, and the two
disulfide bonds are space filled. (B) Stereo view of the conserved VH-VL
interface. For Gln44 and Gln168, the medium-sized black ball represents the
nitrogen atom and the large gray ball represents the oxygen atom. Six of the
key residues involved in the VL-VH packing are also shown as ball and
stick, with all of the atoms colored gray. The VL central strands are shown
as a dotted trace, and the VH central strands are shown as a solid trace.
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ship to the conserved hydrophobic core residues (Chothia et
al., 1985).
Determination of Gn-u and mg
Chemical denaturation studies were used to determine the
folding stability of the native S5 scFv and the site-directed
mutants. These studies were conducted in the absence of
reducing agents, and there are thus two disulfide links
present in the folded and unfolded states. The unfolding
transition was monitored by titrating the change in intrinsic
fluorescence maximum as a function of denaturant concen-
tration. There is a large red shift in the peak intrinsic
fluorescence (14 nm) upon guanidinium denaturation, with-
out a significant alteration in peak intensity (Fig. 2). This
transition was fully reversible upon dilution back through
the curve to zero denaturant concentration (data not shown).
The scFv refolding is reversible through small chaotrope
dilution steps once the correctly disulfide bonded and folded
scFv is isolated. All of the unfolding curves shown in Fig.
3 represent averages of at least five independent experi-
ments, generated from two independent antibody refolding
and purification preparations. The Gn-u and mg values
were determined directly from the raw fluorescence data by
nonlinear fitting using a two-state unfolding model (Santoro
and Bolen, 1988), and significantly stabilized mutants were
also analyzed with the BIOEQS fitting program (Royer,
1993). The data were described well with the two-state
model, and application of a three-state model did not sig-
nificantly improve the goodness of fit. The parameters re-
covered from these analyses and error estimates are reported
in Tables 1 and 2. Although the results in these tables were
obtained from direct fitting of the raw data, we have plotted
the unfolding isotherms on the percentage unfolded axis in
Fig. 3 for easier comparison of the mutants. As previously
discussed, these absolute values should be viewed cau-
tiously (Santoro and Bolen, 1988). The relative Gn-u and
mg are generally quite accurate and provide a reliable
index for comparing the native S5 scFv and the site-directed
mutants (Matouschek et al., 1994).
Ala double mutant cycle
Removing the two hydrogen bonds between Gln44 and
Gln168 by sequentially substituting alanine across the inter-
face has little effect on the unfolding free energy (Table 1).
The Q168A and Q44A/Q168A mutations slightly reduce the
stability of the scFv without significantly altering the mg,
whereas the Q44A mutation results in a small increase in the
folding stability (Fig. 3 A).
Met double mutant cycle
In an attempt to bury more surface area at the VH/VL
interface, we constructed a series of mutants with methio-
nine introduced in different permutations at Gln44 and/or
Gln168. In the first set, a double mutant cycle was con-
structed with the native Gln44/Gln168. Each of the two single
mutants, Q44M/Q168 and Q44/Q168M, displayed signifi-
cant increases in the mg value and the folding free energy
(Table 1 and Fig. 3 B). The double mutant Q44M/Q168M
displayed an unfolding transition with an mg essentially
identical to the native scFv and an increase in stability via a
small shift in Cm.
Ala/Met double mutant cycle
A double mutant cycle was also constructed between the
double alanine and double methionine mutants, to poten-
tially provide a better steric fit in the folded state for the
single methionine mutants. As previously noted, the Q44A/
Q168A displays mg and Gn-u values essentially identical
to those of the wild type, whereas the Q44M/Q168M double
mutant displays a Gn-u of 0.5 kcal/mol. Both the Q44A/
Q168M and Q44M/Q168A mutants display large increases
in mg and Gn-u (Table 1 and Fig. 3 C). The Q44A/Q168M
mutant displays an unfolding isotherm that is more stable
with respect to the denaturant concentration where unfold-
ing is initiated, and then displays a sharply cooperative
transition to the denatured state. The transition is steeper
than the Q168M single mutant, and displays a significantly
increased initial resistance to denaturation. The Q44M/
Q168A isotherm is within experimental error of the Q44M/
Q168 single mutant isotherm.
Glu/Lys double mutant cycles
Double mutant cycles introducing Lys and Glu at positions
44 and 168 were constructed in both directions across the
interface. The mutations in the Q44E/Q168K cycle had little
effect on the folding stability (Table 1 and Fig. 3 D), with
the Q44E and Q168K single mutants displaying Gn-u and
mg values essentially within experimental error of the native
FIGURE 2 Fluorescence emission spectra for the folded scFv (50 mM
Tris, pH 7.5, 150 mMNaCl) and the GnCl-denatured S5 scFv scFv (50 mM
Tris, pH 7.5, 150 mM NaCl, 6 M Gn-HCl). Protein concentration was 0.4
M and sample excitation was at 290 nm.
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antibody. The Q44E/Q168K double mutant was slightly
stabilized relative to wild type, with a small increase in the
mg value. The second cycle, with the salt-bridge polarity
reversed, did display significant alterations (Fig. 3 E).
Whereas the Q168E mutant was within experimental error
of the native isotherm, the Q44K single mutant displayed a
significantly larger and more positive mg and a correspond-
ing increase in Gn-u of 1 kcal/mol. The Q44K/Q168E
double mutant displayed an even larger increase in mg and
a Gn-u of 2 kcal/mol. There was a small but reproduc-
ible fluorescence emission transition at low denaturant con-
centrations with this mutant, which we have assigned to a
local interface effect that is distinct from global folding.
Some uncertainty in the mg and Gn-u values is introduced
by this transition, as the pretransition slope cannot be accu-
rately determined.
FIGURE 3 Guanidine-HCl unfold-
ing titrations for the native scFv and
Q44/Q168 site-directed mutants plot-
ted on the percentage unfolded scale
for visual comparison. The data
points, with standard deviations, rep-
resent averages of at least five unfold-
ing experiments from a minimum of
two independent protein preparations.
The solid lines represent the nonlinear
fits to the two-state folding model. (A)
Native scFv (E), Q44A (), Q168A
(), Q44A/Q168A (‚). (B) Native
scFv (E), Q44M (), Q168M (),
Q44M/Q168M (‚). (C) Native scFv
(E), Q44A/Q168M (), Q44M
Q168A (). (D) Native scFv (E),
Q44E (), Q168K (), Q44E/
Q168K (‚). (E) Native scFv (E),
Q44K (), Q168E (), Q44K/
Q168E (‚).
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Double mutant cycle analyses
Double mutant cycles were constructed from the unfolding
free energies and are summarized in Fig. 4. There are
relatively large interaction free energies of 1.1, 2.4, and
0.8 kcal/mol observed for the methionine, methionine/
alanine, and Lys44/Glu168 complementary charge cycles,
respectively.
EC50 determinations of binding activities
The S5 scFv was previously shown to retain the CD-44
binding affinity of its Fab counterpart in an ELISA-based
EC50 assay (Tan et al., 1995). The C-terminal histidine tag
construct used in this study displayed an equivalent EC50
value when compared to the original construct. The EC50
values for the mutants are summarized in Table 3. The
binding affinity for all mutants was reduced relative to wild
type. The Q44A/Q168M and Q44M/Q168A mutants were
least affected with a relative EC50 of 2.5. With the excep-
tion of the double alanine mutant, the others have relative
EC50’s that range from 3.0 to 4.5. The Q44A/Q168A mutant
displays the largest alteration, with a relative EC50 value of
8.0. Because these assays are conducted with washing steps
in a concentration range that is close to the expected Ka, the
alterations in EC50 could reflect changes in koff and are
likely to represent relatively small alterations on the binding
free energy scale.
Refolding efficiency studies
Table 4 summarizes the refolding efficiencies observed with
selected scFv interface mutants. The refolding of the scFv in
a redox buffer by rapid dilution to nondenaturing conditions
is not reversible, as distinct from the reversibility observed
upon small denaturant dilution steps with a correctly disul-
fide-bonded scFv. The data represented an average of four
to six independent refolding experiments. Two independent
methods of measuring the refolding efficiency were uti-
lized, and the OD280 and micro BCA protein assay results
were in excellent agreement. The refolding efficiency of
wild type is 10%, whereas that of the single methionine
mutants (Q44M and Q168M) is 20–27%. The double
methionine mutant did not produce an additive effect. The
double alanine/methionine mutants also displayed an in-
crease in refolding efficiency, with the Q44A Q168M in-
creasing the refolding efficiency to 21%. The Q44E/Q168K
and Q44K/Q168E mutants displayed little or no increase in
refolding efficiency. The Q44A Q168A mutant displayed a
modest increase over the wild type. The aggregation behav-
FIGURE 4 Double mutant cycle analyses at Gln44/Gln168. The numeri-
cal values represent the unfolding free energies in kcal/mol as recovered
from the analyses reported in Table 1.
TABLE 1B Gnu and mg for salt bridge mutants
Proteins
G*nu
(kcal/mol)
m*g
(kcal/mol/M)
wt 3.20  0.12 1.57  0.04
Q44E 3.33  0.20 1.56  0.06
Q168K 3.30  0.07 1.55  0.04
Q44E Q168K 3.73 0.11 1.87  0.05
Q44K 4.15  0.21 2.10  0.14
Q168E 3.53  0.32 1.78  0.21
Q44K Q168E 5.30 0.20 2.65  0.10
Data given are mean  SD.
TABLE 2 Gnu and mg for selected mutants as analyzed
by BIOEQS
Proteins
G*nu
(kcal/mol)
m*g
(kcal/mol/M)
wt 3.00 [2.74, 3.28] 1.42 [1.29, 1.55]
Q44A Q168M 4.70 [4.42, 5.03] 2.21 [1.97, 2.52]
Q44M Q168A 4.76 [4.30, 5.29] 2.22 [2.01, 2.47]
Q44K Q168E 5.0 [4.00, 6.50] 2.23 [1.80, 2.90]
Data given are mean with 67% confidence limit in [ ].
TABLE 1A Gnu and mg for alanine and
methionine mutants
Proteins
G*nu
(kcal/mol)
m*g
(kcal/mol/M)
wt 3.20  0.12 1.57  0.04
Q44M 3.93  0.08 1.90  0.02
Q168M 4.04  0.23 1.97  0.14
Q44M Q168M 3.70  0.04 1.64  0.04
Q44A 3.76  0.13 1.90  0.08
Q168A 2.86  0.09 1.48  0.10
Q44A Q168A 3.13  0.09 1.58  0.06
Q44A Q168M 4.67  0.11 2.22  0.11
Q44M Q168A 4.50  0.26 2.20  0.13
Data given are mean  SD.
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ior of selected mutants over a period of 300 s after the
initiation of protein refolding is shown in Fig. 5. Most of the
aggregation kinetic pathway is complete during the mixing
time of 3–4 s. The wild-type scFv displays the highest
aggregation, as indicated by the scattering intensity at 500,
and the double methionine mutant (Q44M and Q168M)
displays the lowest level of aggregation. Table 4 summa-
rizes these results.
DISCUSSION
The apparent two-state VH-VL assembly process implies
significant thermodynamic coupling and cooperativity be-
tween the folding and association equilibria. Because the
scFv antibodies are not found in nature, evolutionary pres-
sure has optimized the VH-VL interface in the context of the
closely associated CH1-CL interface. The mutants that dis-
play higher folding free energy also display a loss of bind-
ing free energy, suggesting that the interface is designed to
architecturally optimize antigen recognition rather than
thermodynamic folding stability. The CH1-CL domains and
interface are coupled to VH-VL folding and serve as stabi-
lizing domains, with the VH-VL interface (not just the
complementarity determining loops) properly viewed as an
extension of the “active site” of IgG antibodies. Fersht and
Matthews have previously pointed out that there is no
reason to expect that residues providing key functional roles
in enzymes have also been simultaneously selected for
folding fitness (Schreiber et al., 1994; Shoichet et al., 1995).
A key finding is that despite being remarkably conserved
throughout the IgG antibody family, the Gln44-Gln168 inter-
action is not important to scFv folding stability. The Q44A,
Q168A, and Q44A/Q168A mutants display only very small
alterations in stability that are close to the error limits of our
measurements. In addition to studying the effects of hydro-
gen bond removal, we were interested in testing whether the
hydrophobic interfacial core could be extended by engineer-
ing methionine side chains at Gln44 and Gln168. Several
mutants display stability increases that are relatively large.
Whereas the double Q44M/Q168M mutant displayed an
apparently conventional increase in Gn-u of 0.5 kcal/
mol with constant mg, all of the single methionine mutants
with glutamine or alanine at the complementary position
displayed corresponding positive increases in mg and
Gn-u. With the Q168M mutants, there was significant
benefit to having the smaller alanine side chain at position
44, with an approximate doubling of mg and Gn-u
with Q44A/Q168M relative to Q44/Q168M. The interaction
free energies shown in Fig. 4 must therefore be interpreted
cautiously and may reflect interactions in the unfolded state
as well as the folded state.
The effects of introducing complementary full charges at
Gln44 and Gln168 were strongly dependent on their direc-
tionality across the interface. The Q44E/Q168K orientation
had only a small stabilizing effect, with a correspondingly
small mg alteration. However, the Q44K/Q168E mutant
displayed a large positive change in mg and Gn-u. The
strong directionality dependence of the complementary
charge mutants is likely to involve a local electrostatic
effect, as calculations have suggested that the VH has a
mostly negative surface potential and the VL a complemen-
tary positive potential (Getzoff et al., 1986). Lysine has
polar (48 Å2) and nonpolar (119 Å2) side-chain surface
areas very similar to those of methionine (43 and 117 Å2,
respectively), and the burial of methylene surfaces at the
FIGURE 5 Light scattering measurements of the aggregation kinetics of
scFv hydrogen bonding mutants. The experimental conditions are de-
scribed in Materials and Methods.
TABLE 3 EC50 data from competitive ELISA binding assays
Proteins EC50 (nM)
wt 0.18  0.01
Q44M 0.80  0.15
Q168M 0.73  0.07
Q44M Q168M 0.71  0.05
Q44A 0.61  0.02
Q168A 0.87  0.01
Q44A Q168A 1.59  0.30
Q44A Q168M 0.45  0.04
Q44M Q168A 0.47  0.02
Q44K Q168E 0.67 0.08
Q44E Q168K 0.75 0.05
TABLE 4 Refolding efficiency of wild-type and hydrogen-
bonding mutants
Proteins Refolding efficiency* Refolding efficiency#
wt 9.3  2.8 8  3.9
Q44M 22.4  5.0 19.5  5.7
Q168M 27  3.4 21.2  4.8
Q44M
Q168M
25.5  6.0 26.2  6.0
Q44A
Q168M
21.8  6.0 20.3  6.9
Q44M
Q168A
15.3  3.8 17.7  6.2
Q44A Q168A 14.5  3.7 13  6.0
Q44E Q168K 15.7  4.4 12.5  4.6
Q44K Q168E 12.6  3.8 9.9  4.5
*Refolding efficiency determined by OD280 quantitation.
#Refolding efficiency determined by BCA measurements.
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interface could also play an important role in the stabiliza-
tion of the VH/VL association, or have significant effects on
the unfolded states.
Rowe has pointed out that the unfolding of two antibody
domains connected by a covalent linker can be described as
the product of a pseudodissociation constant and the equi-
librium constants for the unfolding of the two individual
domains (1976):
Knu KdKVHKVL
where Kn-u is the equilibrium constant for the unfolding of
the scFv, Kd is the unimolecular VH-VL dissociation con-
stant, and KVH/KVL are the equilibrium constants for the
unfolding of the individual VH and VL subunits. A sche-
matic model of this unfolding scheme, which has also been
used by Pantoliano and co-workers in the context of scFv
stability (1991), is shown in Fig. 6. Brandts has developed
an explicit derivation of its consequences to examine the
calorimetric deconvolution of interacting folding domains
(1989). At one limit is the strong coupling case, in which the
association is tight and a higher concentration of denaturant
is required to unfold the protein than is required for unfold-
ing the isolated domains. The association energy keeps the
subunits folded at a denaturant concentration where they
would normally be unfolded. In the weak coupling limit, the
domain unfolding occurs at a significantly higher denaturant
concentration than dissociation, so that the observed unfold-
ing titration is largely a function of the relative properties of
the isolated subunits.
If the altered subunit interface results in a higher associ-
ation free energy (smaller Kd), then the initiation of un-
folding could be shifted to higher denaturant concentrations.
The coupling between association and unfolding is more
closely linked, and the increase in association energy results
in an increase in mg. The mg term in chemical denaturation
studies has previously been related to An-u (Shortle and
Meeker, 1986; Shortle, 1995; Myers et al., 1995). The
site-directed mutation(s) could thus also give rise to a
mg via an increase in the surface area of the unfolded
state (with KVH and/or KVL altered by a shift in the free
energy of the unfolded state). The scFv have one disulfide
bond in each of VH and VL domains, and these are likely to
impart a degree of structure in the unfolded state (Myers et
al., 1995). Some of the mutations could further disrupt this
vestigial structure toward a more solvent-accessible, ex-
tended state.
Another principal means by which mutations could result
in mg is under conditions where the two-state assumption
is altered. It is often experimentally difficult to distinguish
whether an equilibrium denaturation curve reflects small
accumulations of folding intermediates because of data fit-
ting uncertainties, and a mg could reflect a shift toward
higher cooperativity and true two-state behavior (or vice
versa). This could arise in the context of Fig. 6 when the
wild-type association free energy is relatively small, and the
system is not completely coupled to a two-state equilibrium.
Our use of a three-state fitting model did not result in a
better fit to the unfolding data, but we cannot rule out this
possibility.
A significant limitation with the production of many scFv
is poor refolding efficiency. The low refolding yield is often
attributed to the irreversible side reactions, such as protein
aggregation (Jaenicke, 1887; London et al., 1974; Zettl-
meissl et al., 1979). Pluckthun and co-workers have re-
ported that mutations in the framework region of a single-
chain Fv greatly reduced aggregation and improved
refolding yield (Knappick and Pluckthun, 1995). We
checked to see whether any of the S5 scFv mutants had
altered refolding efficiencies to probe the role of VH/VL
interface in the refolding pathway and to see if thermody-
namic stability was correlated with refolding efficiency. We
used the reduced scFv as a starting point, whereas Knappick
and Pluckthun utilized disulfide-intact scFv. There were
significant alterations in the refolding efficiencies, as sum-
marized in Table 4. There was not a correlation between
aggregation and thermodynamic stabilities. This suggests
that it is indeed a kinetic step that is being altered by the
VH/VL interface mutations, such as an increase in the rate of
native refolding or a decrease in the committed rate con-
trolling the aggregation partition. The finding that VH/VL
interface mutations can significantly increase refolding ef-
ficiencies could provide a new avenue for optimizing pro-
duction strategies.
CONCLUSIONS
There are three primary mechanisms available for increas-
ing the thermodynamic stability of scFv antibodies: 1) in-
crease the VH/VL association free energy, 2) destabilize the
scFv unfolded state, or 3) increase the stability of isolated
VH and/or VL domains. Several of the Gln44/Gln168 mutants
display significantly increased mg and Gn-u values, which
we have qualitatively interpreted as being due to an increase
in the VH/VL association free energy and/or a perturbation
of the scFv unfolded state. The effect of improving VH/VL
interactions can be described as an increase in cooperativity,
where the increased association free energy keeps the VH
and VL folded at denaturant concentrations at which the
isolated domains would be unfolded. Although the VH/VL
interface mutations reduce the antigen binding affinity to a
small extent, these studies suggest that reengineering of the
VH/VL interface may thus provide new avenues for improv-
ing scFv stability and refolding efficiency.
FIGURE 6 Schematic model for the unfolding of scFv as adapted from
Rowe (1976).
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